These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
643 related items for PubMed ID: 18691308
1. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Kemp SF, Lockey RF, Simons FE, World Allergy Organization ad hoc Committee on Epinephrine in Anaphylaxis. Allergy; 2008 Aug; 63(8):1061-70. PubMed ID: 18691308 [Abstract] [Full Text] [Related]
2. Epinephrine: the drug of choice for anaphylaxis-a statement of the world allergy organization. Kemp SF, Lockey RF, Simons FE, World Allergy Organization ad hoc Committee on Epinephrine in Anaphylaxis. World Allergy Organ J; 2008 Jul; 1(7 Suppl):S18-26. PubMed ID: 23282530 [Abstract] [Full Text] [Related]
7. Repeated epinephrine doses: An analysis of the European Anaphylaxis Registry, 2007-2018. Grabenhenrich LB, Fernández-Rivas M, Dölle-Bierke S, Worm M. J Allergy Clin Immunol Pract; 2019 Jul; 7(8):2935-2937. PubMed ID: 31170538 [No Abstract] [Full Text] [Related]
8. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community. Sicherer SH, Simons FE. J Allergy Clin Immunol; 2005 Mar; 115(3):575-83. PubMed ID: 15753907 [Abstract] [Full Text] [Related]
9. Lack of worldwide availability of epinephrine autoinjectors for outpatients at risk of anaphylaxis. Simons FE. Ann Allergy Asthma Immunol; 2005 May; 94(5):534-8. PubMed ID: 15945555 [Abstract] [Full Text] [Related]
20. Confusion about epinephrine dosing leading to iatrogenic overdose: a life-threatening problem with a potential solution. Kanwar M, Irvin CB, Frank JJ, Weber K, Rosman H. Ann Emerg Med; 2010 Apr; 55(4):341-4. PubMed ID: 20031267 [Abstract] [Full Text] [Related] Page: [Next] [New Search]